Camel-IDS is a spin-off company of the VUB developing cancer-targeted radiopharmaceuticals. It secured EUR 37m in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co-lead investors HealthCap (Sweden), Nov...

De Week Van